Bulletin of the World Health Organization

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa

Yoel Lubell, Arthorn Riewpaiboon, Arjen M Dondorp, Lorenz von Seidlein, Olugbenga A Mokuolu, Margaret Nansumba, Samwel Gesase, Alison Kent, George Mtove, Rasaq Olaosebikan, Wirichada Pan Ngum, Caterina I Fanello, Ilse Hendriksen, Nicholas PJ Day, Nicholas J White & Shunmay Yeung

Volume 89, Number 7, July 2011, 504-512

Table 4. Mean malaria inpatient treatment costs (in United States dollars, US$) in each study arm according to cost category and study site

Cost category Teule
Korogwe
Mbarara
Ilorin
All sites
QNN ART QNN ART QNN ART QNN ART QNN ART
Trial drug 1.2 (1.8)a 2.8 (4.1) 1.6 (2.8) 3.5 (6.4) 1.2 (2.0) 3.7 (6.2) 1.2 (1.3) 3.5 (3.2) 1.3 (2.0) 3.3 (4.9)
Drugs 3.4 (5.1) 3.4 (5.0) 3.8 (6.8) 3.4 (6.2) 1.9 (3.2) 1.6 (2.6) 3.2 (3.7) 2.7 (2.4) 3 (4.7) 2.9 (4.3)
Fluids 12.3 (18) 12.2 (18) 16.7 (30) 12.3 (22) 13.1 (22) 12.5 (20) 11.6 (13) 13.6 (12) 13.5 (21) 12.5 (18)
Laboratories 18.4 (28) 18.2 (27) 10.5 (18) 10.4 (19) 5.9 (10) 5.9 (9.8) 3.5 (4.0) 4.9 (4.5) 11.6 (18) 11.5 (17)
Hotel 30.2 (46) 30.1 (45) 23 (41) 24.4 (45) 36.5 (62) 35.9 (60) 66.7 (77) 84 (77) 34.1 (53) 36.3 (54)
Total 65.5 (100) 66.7 (100) 55.6 (100) 54 (100) 58.6 (100) 59.6 (100) 86.2 (100) 108.7 (100) 63.5 (100) 66.5 (100%)

ART, artesunate; QNN, quinine.

a The figures in parentheses represent the percentage of total costs.